Edison Scientific, an AI startup focused on accelerating scientific research, has raised $70 million in funding. The company is developing AI software designed to automate and expedite scientific processes. The funding round was jointly led by Spark Capital, Triatomic Capital, and an unnamed biotech investor, with participation from notable figures such as Google's Jeff Dean and CrowdStrike's Dmitri Alperovitch.
Edison Scientific aims to provide researchers with an AI platform capable of synthesising literature, analysing data, and designing molecules, thereby accelerating discoveries across various fields. Their AI scientist platform facilitates research, from data analysis to molecular design. Kosmos, Edison Scientific's AI co-scientist, supports literature review, data analysis, and hypothesis generation. The company's technology has shown promise in identifying therapeutic targets and elucidating complex molecular structures.
Edison Scientific was spun out of FutureHouse to commercialise AI research tools and develop new ones for laboratories and research institutes. The company is committed to maintaining a free tier while offering paid features for power users.
